KIM YONG MAN enters NKGEN BIOTECH, INC. with 28.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/10/2023ACC: 0001209191-23-052516
Officer· CSO and CIO
Since Sep 2023
28.38K
Baseline shares
100% direct
28.38K
Direct ownership
1 position
133.45K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned28.38K
Total
28.38K direct28.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.38K | Direct |
| Total | 28.38K | 28.38K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
133.45K
Shares owned
N/A
Exercise price
6.67
Expiration
—
Exercise window
—
Total
Underlying
133.45K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 6.67 | — | — | 133.45K | N/A |
| Total | 133.45K | 0.00 | ||||